Gráfico del Precio de Acciones ONCO
ONCO Precio
Onconetix Inc
$0.38
-5.94%
$-0.02
Al cierre: May 08, 16:00:00 GMT-4
$0.36
-3.1%
$-0.01
Mercado Posterior: May 08, 20:00:00 GMT-4
Atrás
Onconetix Inc (ONCO) Precio
Estadísticas clave
Cierre Anterior
$0.404
Precio de apertura
$0.3955
Rango del día
$0.36 - $0.4
Rango de 52 semanas
$0.3682 - $74.3
Volumen
852.2K
Volumen promedio
3.9M
Rendimiento de dividendos
--
EPS (TTM)
-74.35
Cap. de mercado
$254.0K
¿Qué es ONCO?
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company is headquartered in Cincinnati, Ohio. The company went IPO on 2022-02-18. The firm owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.
Características
© 2026 Edgen impulsado por
